S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors

NCT00937417 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

NETWORK

Sponsor class

Stopped Withdrawn because SWOG no longer pursuing this study at this time

Conditions

Breast Cancer
Head and Neck Cancer
Lung Cancer
Prostate Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: docetaxel
DRUG: vandetanib
GENETIC: proteomic profiling
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]